# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-024426
Filing Date
2026-05-19
Accepted
2026-05-19 16:30:58
Documents
69
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1640216
2 | EX-10.2 | ex10-2.htm | EX-10.2 | 20734
3 | EX-31.1 | ex31-1.htm | EX-31.1 | 12169
4 | EX-31.2 | ex31-2.htm | EX-31.2 | 12094
5 | EX-32.1 | ex32-1.htm | EX-32.1 | 7888
6 | EX-32.2 | ex32-2.htm | EX-32.2 | 8156
7 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 4645
8 | GRAPHIC | form10-q_002.jpg | GRAPHIC | 18598
9 | GRAPHIC | form10-q_003.jpg | GRAPHIC | 8323
10 | GRAPHIC | form10-q_004.jpg | GRAPHIC | 8950
11 | GRAPHIC | form10-q_005.jpg | GRAPHIC | 13482
| Complete submission text file | 0001493152-26-024426.txt |  | 9163696

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | mgrx-20260331.xsd | EX-101.SCH | 65134
13 | XBRL CALCULATION FILE | mgrx-20260331_cal.xml | EX-101.CAL | 54444
14 | XBRL DEFINITION FILE | mgrx-20260331_def.xml | EX-101.DEF | 356661
15 | XBRL LABEL FILE | mgrx-20260331_lab.xml | EX-101.LAB | 551035
16 | XBRL PRESENTATION FILE | mgrx-20260331_pre.xml | EX-101.PRE | 448119
72 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1238395

Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 26999361
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)